Skip to main content

Prehypertension: Definitions, Clinical Significance and Therapeutic Approaches—To Treat or not to Treat?

  • Chapter
  • First Online:

Abstract

Because of its large prevalence and association with higher cardiovascular (CV) risk, prehypertension negatively affects public health. Prehypertension starts as a minor blood pressure (BP) elevation in childhood and young adulthood. Thereafter, BP in the prehypertension group increases steeply. This BP acceleration is associated with the restructuring of resistance arteries. In rats with spontaneous hypertension (SHR) and in humans, lowering BP with drugs that act on the renin–angiotensin system reverses arteriolar changes. In SHR, a short period of early treatment prevented subsequent accelerated hypertension. We investigated whether in prehypertension a period of treatment may postpone the development of hypertension. Two years after discontinuation of treatment, there was a modest suppression of new hypertension. Guidelines suggest lifestyle modifications for the management of prehypertension, but treatment can be initiated in patients with additional CV risk factors.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Robinson SC, Brucer M (1939) Range of normal blood pressure. A statistical and clinical study of 11,383 persons. Arch Intern Med 64:409–444

    Article  Google Scholar 

  2. Julius S, Schork MA (1971) Borderline hypertension–a critical review. J Chronic Dis 23:723–754

    Article  PubMed  CAS  Google Scholar 

  3. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (1997) Arch Intern Med 157:2413–2446

    Google Scholar 

  4. 1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting (1993) J Hypertens 11:905–918

    Google Scholar 

  5. Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187

    Article  PubMed  CAS  Google Scholar 

  6. Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572

    Article  PubMed  CAS  Google Scholar 

  7. Neaton JD, Kuller, L, Stamler, J et al (1995) Impact of systolic and diastolic blood pressure on cardiovascular mortality. In: Laragh JH, Brenner, BM (eds) Hypertension. Pathophysiology, diagnosis and management, vol 1, 2nd edn. Raven Press Ltd New York, pp 127–144

    Google Scholar 

  8. Egan BM, Julius S (2008) Prehypertension: risk stratification and management considerations. Curr Hypertens Rep 10:359–366

    Article  PubMed  Google Scholar 

  9. Julius S, Nesbitt SD, Egan BM et al (2006) Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 354:1685–1697

    Article  PubMed  CAS  Google Scholar 

  10. Mancia G, Facchetti R, Bombelli M et al (2006) Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47:846–853

    Article  PubMed  CAS  Google Scholar 

  11. Sega R, Trocino G, Lanzarotti A et al (2001) Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 104:1385–1392

    Article  PubMed  CAS  Google Scholar 

  12. Pierdomenico SD, Cuccurullo F (2011) Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 24:52–58

    Article  PubMed  Google Scholar 

  13. Julius S, Jamerson K, Mejia A et al (1990) The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh blood pressure study. JAMA 264:354–358

    Article  PubMed  CAS  Google Scholar 

  14. Palatini P, Julius S (1997) Heart rate and the cardiovascular risk. J Hypertens 15:3–17

    Article  PubMed  CAS  Google Scholar 

  15. Julius S, Pascual AV, Reilly K et al (1971) Abnormalities of plasma volume in borderline hypertension. Arch Intern Med 127:116–119

    Article  PubMed  CAS  Google Scholar 

  16. Smith S, Julius J, Jamerson K (1994) Hemotocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. J Hypertens 12:455–462

    Article  PubMed  CAS  Google Scholar 

  17. Nesbitt SD, Julius S, Leonard D et al (2005) For the TROPHY study investigators is low-risk hypertension fact or fiction? Am J Hypertens 18:980–985

    Google Scholar 

  18. Chen X, Wang Y (2008) Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation 117:3171–3180

    Article  PubMed  Google Scholar 

  19. Tirosh A, Afek A, Rudich A et al (2010) Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension 56:203–209

    Article  PubMed  CAS  Google Scholar 

  20. London GM, Safar ME, Sassard JE et al (1984) Renal and systemic hemodynamics in sustained essential hypertension. Hypertension 6:743–754

    Article  PubMed  CAS  Google Scholar 

  21. Wong TY, Shankar A, Klein R et al (2004) Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ 329:79

    Article  PubMed  Google Scholar 

  22. Mulvany MJ (2003) Structural abnormalities of the resistance vasculature in hypertension. J Vasc Res 40:558–560

    Article  PubMed  Google Scholar 

  23. Folkow B (1987) Structure and function of the arteries in hypertension. Am Heart J 114:938–948

    Article  PubMed  CAS  Google Scholar 

  24. Furuyama M (1962) Histometrical investigations of arteries in reference to arterial hypertension. Tohoku J Exp Med 76:388–414

    Article  PubMed  CAS  Google Scholar 

  25. Short D (1966) Morphology of the intestinal arterioles in chronic human hypertension. Br Heart J 28:184–192

    Article  PubMed  CAS  Google Scholar 

  26. Heagerty AM, Aalkjaer C, Bund SJ et al (1993) Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 21:391–397

    Article  PubMed  CAS  Google Scholar 

  27. Mulvany MJ, Aalkjaer C (1990) Structure and function of small arteries. Physiol Rev 70:921–961

    PubMed  CAS  Google Scholar 

  28. Egan B, Panis R, Hinderliter A et al (1987) Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 80:812–817

    Article  PubMed  CAS  Google Scholar 

  29. Panza JA, Casino PR, Kilcoyne CM et al (1993) Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87:1468–1474

    Article  PubMed  CAS  Google Scholar 

  30. Harrap SB, Van der Merwe WM, Griffin SA et al (1990) Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 16:603–614

    Article  PubMed  CAS  Google Scholar 

  31. Nakaya H, Sasamura H, Hayashi M et al (2001) Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis. J Am Soc Nephrol 12:659–666

    PubMed  CAS  Google Scholar 

  32. Schiffrin EL (2004) Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17:1192–1200

    Article  PubMed  CAS  Google Scholar 

  33. Williams B, Lacy PS, Thom SM et al (2006) Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation 113:1213–1225

    Article  PubMed  CAS  Google Scholar 

  34. Julius S, Pascual AV, Sannerstedt R et al (1971) Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 43:382–390

    Article  PubMed  CAS  Google Scholar 

  35. Flaa A, Eide IK, Kjeldsen SE et al (2008) Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study. Hypertension 52:336–341

    Article  PubMed  CAS  Google Scholar 

  36. Cowley AW Jr, Liard JF, Guyton AC (1973) Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res 32:564–576

    Article  PubMed  Google Scholar 

  37. Julius S, Li Y, Brant D et al (1989) Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy. Hypertension 13:422–429

    Article  PubMed  CAS  Google Scholar 

  38. Appel LJ, Moore TJ, Obarzanek E et al (1997) A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med 336:1117–1124

    Article  PubMed  CAS  Google Scholar 

  39. Appel LJ, Champagne CM, Harsha DW et al (2003) Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 289:2083–2093

    Article  PubMed  Google Scholar 

  40. Appel LJ, Clark JM, Yeh HC et al (2011) Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med 365:1959–1968

    Article  PubMed  CAS  Google Scholar 

  41. Julius S, Kaciroti N, Egan BM et al (2008) TROPHY study: Outcomes based on the seventh report of the Joint National Committee on Hypertension definition of hypertension. J Am Soc Hypertens 2:39–43

    Article  PubMed  Google Scholar 

  42. Luders S, Schrader J, Berger J et al (2008) The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure. J Hypertens 26:1487–1496

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stevo Julius .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Julius, S., Feldstein, C.A. (2012). Prehypertension: Definitions, Clinical Significance and Therapeutic Approaches—To Treat or not to Treat?. In: Berbari, A., Mancia, G. (eds) Special Issues in Hypertension. Springer, Milano. https://doi.org/10.1007/978-88-470-2601-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2601-8_1

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2600-1

  • Online ISBN: 978-88-470-2601-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics